Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Coler

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Parasite Immunology|August 21, 2009
Adjuvants for malaria vaccinesR N Coler, D Carter, M Friede, et al.
Progress in Molecular Biology and Translational Science|August 31, 2016
Translational Activities to Enable NTD VaccinesS A Gray, R N Coler, D Carter, et al.
Expert Review of Vaccines|November 24, 2015
Leishmania vaccine development: exploiting the host-vector-parasite interfaceS G Reed, R N Coler, D Mondal, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 20, 2001
Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case reportR Badaro, I Lobo, M Nakatani, et al.
Infection and Immunity|May 16, 2002
Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c miceA Campos-Neto, J R Webb, K Greeson, et al.
Infection and Immunity|May 12, 2001
Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human diseaseA Campos-Neto, R Porrozzi, K Greeson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosisR N Coler, Y A Skeiky, T Vedvick, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 19, 2013
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasisA C Vallur, M S Duthie, C Reinhart, et al.
The Journal of Infectious Diseases|July 7, 2000
Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivityR N Coler, Y A Skeiky, P J Ovendale, et al.
Tuberculosis (Edinburgh, Scotland)|January 22, 2002
Evaluation of DPPD, a single recombinant Mycobacterium tuberculosis protein as an alternative antigen for the Mantoux testA Campos-Neto, V Rodrigues-Júnior, D B Pedral-Sampaio, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Parasite Immunology|August 21, 2009
Adjuvants for malaria vaccinesR N Coler, D Carter, M Friede, et al.
Progress in Molecular Biology and Translational Science|August 31, 2016
Translational Activities to Enable NTD VaccinesS A Gray, R N Coler, D Carter, et al.
Expert Review of Vaccines|November 24, 2015
Leishmania vaccine development: exploiting the host-vector-parasite interfaceS G Reed, R N Coler, D Mondal, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 20, 2001
Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case reportR Badaro, I Lobo, M Nakatani, et al.
Infection and Immunity|May 16, 2002
Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c miceA Campos-Neto, J R Webb, K Greeson, et al.
Infection and Immunity|May 12, 2001
Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human diseaseA Campos-Neto, R Porrozzi, K Greeson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosisR N Coler, Y A Skeiky, T Vedvick, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 19, 2013
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasisA C Vallur, M S Duthie, C Reinhart, et al.
The Journal of Infectious Diseases|July 7, 2000
Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivityR N Coler, Y A Skeiky, P J Ovendale, et al.
Tuberculosis (Edinburgh, Scotland)|January 22, 2002
Evaluation of DPPD, a single recombinant Mycobacterium tuberculosis protein as an alternative antigen for the Mantoux testA Campos-Neto, V Rodrigues-Júnior, D B Pedral-Sampaio, et al.
Pageof 2